Related Experiment Videos
A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR.
Giovanni Cianchetta1, Robert W Singleton, Meng Zhang
1Sanofi-Aventis Pharmaceuticals, 1041 Rt 202-206N, Bridgewater, New Jersey 08807, USA.
Journal of Medicinal Chemistry
|April 15, 2005
Summary
This study identified key molecular features for P-glycoprotein substrates using 3D-QSAR. Pharmacophore models reveal that specific hydrophobic and hydrogen-bonding group arrangements are crucial for substrate recognition and efflux.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- P-glycoprotein (P-gp) is a crucial efflux transporter involved in drug resistance.
- Understanding substrate interactions with P-gp is vital for drug development.
Purpose of the Study:
- To develop a robust model for predicting P-glycoprotein substrates.
- To elucidate the key pharmacophoric features governing substrate recognition by P-gp.
Main Methods:
- Evaluated 129 diverse compounds for P-gp inhibition using a calcein-AM assay.
- Performed 3D-QSAR analysis utilizing GRIND pharmacophore and physicochemical descriptors.
- Employed Partial Least Squares (PLS) statistical analysis to correlate descriptors with inhibition.
Main Results:
- Pharmacophore-based descriptors yielded a more robust QSAR model compared to physicochemical descriptors.
- A strong correlation was observed between pharmacophoric features and P-gp inhibition.
- Identified a pharmacophore model with two hydrophobic groups (16.5 Å apart) and two hydrogen-bond acceptors (11.5 Å apart) critical for substrate recognition.
Conclusions:
- Substrate recognition by P-glycoprotein is primarily driven by specific molecular interactions rather than membrane diffusion.
- The identified pharmacophore provides insights into the structural requirements for P-gp substrate binding.
- This model can aid in the design of novel compounds with modulated P-gp interaction for therapeutic applications.